Sioris Thanos, Sihvo Eero, Sankila Risto, Salo Jarmo
Tampere University Hospital, Heart Center, P.O. Box 2000, FIN-33521 Tampere, Finland.
Lung Cancer. 2008 Jan;59(1):119-25. doi: 10.1016/j.lungcan.2007.07.020. Epub 2007 Sep 10.
Hospital mortality and long-term survival in major cancer surgery seems to be affected by hospital related factors. We evaluated the effect of university versus non-university hospital type, and surgical volume (0-4, 5-10, 11-20, and >20 average of cases/year) on the immediate and long-term survival of surgical non-small cell lung cancer (NSCLC) patients.
Between 1988 and 2002, the number of NSCLC resections with curative intent in Finland was 5339. Follow-up until the end of 2003 from national registries was available on 91% (4878 of 5339) of patients.
Multivariate analysis showed that hospital mortality was unaffected by hospital type or volume, but delay of >4 months from diagnosis to surgery did have an adverse effect. Surgery at university hospitals was associated with significantly better cancer-related and overall survival, as also was surgery at very low-volume but mainly private hospitals (0-4 cases/year).
Undergoing surgery for non-small cell lung cancer at a university hospital may offer an advantage for long-term survival, but large hospital volume in itself did not.
Multivariate analysis on the effect of hospital type and surgical volume on immediate and long-term survival of 4878 lung cancer surgery patients, 1988-2002, showed that surgery at university hospitals was associated with significantly better cancer-related and overall survival, but hospital mortality did not differ. Large hospital volume did not independently predict a better outcome.
重大癌症手术的医院死亡率和长期生存率似乎受医院相关因素影响。我们评估了大学医院与非大学医院类型以及手术量(每年平均病例数为0 - 4、5 - 10、11 - 20和>20)对手术治疗非小细胞肺癌(NSCLC)患者近期和长期生存的影响。
1988年至2002年间,芬兰有5339例有治愈意向的NSCLC切除术。91%(5339例中的4878例)患者可从国家登记处获得直至2003年底的随访信息。
多因素分析显示,医院死亡率不受医院类型或手术量影响,但从诊断到手术延迟>4个月确实有不利影响。在大学医院进行手术与显著更好的癌症相关生存率和总生存率相关,在手术量极低但主要为私立医院(每年0 - 4例)进行手术也是如此。
在大学医院进行非小细胞肺癌手术可能对长期生存有优势,但医院手术量本身并无此优势。
对1988 - 2002年间4878例肺癌手术患者的医院类型和手术量对近期和长期生存影响的多因素分析显示,在大学医院进行手术与显著更好的癌症相关生存率和总生存率相关,但医院死亡率无差异。大医院手术量并不能独立预测更好的结果。